Prakash Vishnu

2.0k total citations · 1 hit paper
67 papers, 1.4k citations indexed

About

Prakash Vishnu is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, Prakash Vishnu has authored 67 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 21 papers in Oncology and 15 papers in Surgery. Recurrent topics in Prakash Vishnu's work include Platelet Disorders and Treatments (13 papers), Lymphoma Diagnosis and Treatment (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (9 papers). Prakash Vishnu is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Lymphoma Diagnosis and Treatment (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (9 papers). Prakash Vishnu collaborates with scholars based in United States, Germany and Switzerland. Prakash Vishnu's co-authors include David M. Aboulafia, Vivek Roy, Aneel A. Ashrani, Alfonso Tafur, Daniel M. Anderson, Tyler Zemla, Usha Perepu, Robert D. McBane, Roberto A. Leon Ferre and Euphemia Leung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Prakash Vishnu

58 papers receiving 1.3k citations

Hit Papers

Apixaban and dalteparin i... 2019 2026 2021 2023 2019 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Prakash Vishnu 382 302 297 274 247 67 1.4k
Lidia Gil 135 0.4× 123 0.4× 414 1.4× 413 1.5× 170 0.7× 136 1.2k
J. Mark Sloan 219 0.6× 150 0.5× 510 1.7× 529 1.9× 1.0k 4.2× 143 2.4k
Andrés J. Muñoz Martín 1.2k 3.2× 906 3.0× 191 0.6× 551 2.0× 145 0.6× 131 2.0k
Eduardo Ramacciotti 693 1.8× 549 1.8× 321 1.1× 103 0.4× 185 0.7× 82 1.4k
B. Gail Macik 147 0.4× 120 0.4× 947 3.2× 101 0.4× 140 0.6× 32 1.9k
Hamid Al‐Mondhiry 159 0.4× 148 0.5× 697 2.3× 199 0.7× 178 0.7× 89 2.1k
Robert Bona 1.2k 3.2× 727 2.4× 937 3.2× 145 0.5× 196 0.8× 60 2.4k
Yeung‐Chul Mun 125 0.3× 92 0.3× 634 2.1× 647 2.4× 422 1.7× 149 1.8k
Pavan K. Bendapudi 315 0.8× 104 0.3× 401 1.4× 345 1.3× 217 0.9× 56 2.0k
Jiro Inagaki 65 0.2× 99 0.3× 496 1.7× 451 1.6× 188 0.8× 90 1.5k

Countries citing papers authored by Prakash Vishnu

Since Specialization
Citations

This map shows the geographic impact of Prakash Vishnu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prakash Vishnu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prakash Vishnu more than expected).

Fields of papers citing papers by Prakash Vishnu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prakash Vishnu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prakash Vishnu. The network helps show where Prakash Vishnu may publish in the future.

Co-authorship network of co-authors of Prakash Vishnu

This figure shows the co-authorship network connecting the top 25 collaborators of Prakash Vishnu. A scholar is included among the top collaborators of Prakash Vishnu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prakash Vishnu. Prakash Vishnu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vishnu, Prakash, et al.. (2024). Comparison of Trifecta and Pentafecta Outcomes across 3 Surgical Modalities of Partial Nephrectomy (PN) – Open, Lap, and Robotic. SHILAP Revista de lepidopterología. 11(3). 27–32.
2.
Hamzeh‐Cognasse, Hind, Janna Hastings, Jan–Dirk Studt, et al.. (2024). Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. Blood Advances. 8(11). 2825–2834. 5 indexed citations
3.
Srikanth, Narayanam, et al.. (2023). Removal of Fluorides Using a Low-Cost Adsorbent. 10(1). 126–133. 1 indexed citations
4.
Dholaria, Bhagirathbhai, Nancy N. Diehl, Aaron Spaulding, et al.. (2020). Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features. SHILAP Revista de lepidopterología. 2(3). 117–117. 1 indexed citations
5.
Kumar, Vivek, Sikander Ailawadhi, Aditya Mehta, et al.. (2019). Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia. Blood Cancer Journal. 9(10). 75–75. 44 indexed citations
6.
Hsieh, Ronan W., Aishwarya Ravindran, C. Christopher Hook, et al.. (2019). Etiologies of Extreme Thrombocytosis: A Contemporary Series. Mayo Clinic Proceedings. 94(8). 1542–1550. 10 indexed citations
7.
McBane, Robert D., Waldemar E. Wysokiński, Jennifer Le‐Rademacher, et al.. (2019). Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial. Journal of Thrombosis and Haemostasis. 18(2). 411–421. 375 indexed citations breakdown →
8.
Ghoz, Hassan, Paul T. Kröner, Fernando F. Stancampiano, et al.. (2019). Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of non-diagnostic elastography. Quantitative Imaging in Medicine and Surgery. 9(6). 921–927. 24 indexed citations
9.
Azzouqa, Abdel‐Ghani, et al.. (2018). Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases. Hematology Reports. 10(3). 7658–7658. 3 indexed citations
10.
Vishnu, Prakash, et al.. (2018). Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers. BMJ Case Reports. 2018. bcr–2018. 2 indexed citations
11.
Dholaria, Bhagirathbhai, Prakash Vishnu, Vivek Roy, et al.. (2017). DA.R-EPOCH Vs. R-CHOP for High-Risk Diffuse Large B- Cell Lymphoma: The Mayo Clinic Florida Experience. Blood. 130. 1572–1572.
13.
Vishnu, Prakash, et al.. (2016). Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia. Journal of Blood Medicine. 7. 99–99. 20 indexed citations
14.
Vishnu, Prakash. (2013). Lymphoproliferative disorders following solid organ transplantation. Surgery Current Research.
15.
Vishnu, Prakash, et al.. (2012). NEEDLE FREE INJECTION TECHNOLOGY: A REVIEW. International Journal of Pharmacy. 2(1). 148–155. 5 indexed citations
16.
Colón‐Otero, Gerardo, Jennifer A. Weis, Timothy A. Woodward, et al.. (2011). A Pilot Program in Collaboration with African American Churches Successfully Increases Awareness of the Importance of Cancer Research and Participation in Cancer Translational Research Studies among African Americans. Journal of Cancer Education. 27(2). 294–298. 6 indexed citations
17.
Vishnu, Prakash, Gerardo Colón‐Otero, Gregory T. Kennedy, et al.. (2011). RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer. Gynecologic Oncology. 124(3). 589–597. 14 indexed citations
18.
Chen, Guoan, Xiaoju Wang, Jianjun Yu, et al.. (2007). Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma. Cancer Research. 67(7). 3461–3467. 73 indexed citations
19.
Bayliss, Jill, et al.. (2007). Reversal of the Estrogen Receptor–Negative Phenotype in Breast Cancer and Restoration of Antiestrogen Response. Clinical Cancer Research. 13(23). 7029–7036. 93 indexed citations
20.
Vishnu, Prakash, Sridhar Srinivasan, Andrew T. Turrisi, et al.. (2007). P2-220: Radiation pneumonitis (RP) in lung cancer patients treated with chemotherapy (CT) and thoracic radiation (TR): Retrospective analyses of patients treated at a comprehensive cancer center. Journal of Thoracic Oncology. 2(8). S659–S660. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026